Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

BACKGROUND: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Med Oncol
Glavni autori: Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Leonardi, Francesca, Londei, Davide, Padovan, Marta, Caccese, Mario, Marchione, Giulia, Bini, Silvia, Zagonel, Vittorina, Frizziero, Luisa
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278095/
https://ncbi.nlm.nih.gov/pubmed/32550861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920907543
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items